Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum
Bun KIM; Ji-Hye HUH; Youngsook KIM; Moon-Jae CHUNG; Jeong-Youp PARK; Si-Young SONG; Seung-Woo PARK.
The Korean Journal of Internal Medicine
; : 96-100, 2014.
Artículo
en Inglés
| WPRIM | ID: wpr-155074
Primary duodenal adenocarcinoma is a rare malignant neoplasm accounting for 0.3% of all gastrointestinal tract carcinomas. We herein present one case of duodenal adenocarcinoma after duodenal neuroendocrine carcinoma. Poorly differentiated duodenal neuroendocrine carcinoma with liver metastasis (TxNxM1) was confirmed, and eight cycles of palliative chemotherapy (5-fluorouracil/etoposide/cisplatin) were administered. The patient was then in a clinically complete response status. About 1 year later, newly developed adenocarcinoma was detected at the same site. It was completely surgically resected, and the patient was cured.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados